Close

Ratings by Raymond James (Danielle Brill)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/2/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Outperform
(N/A)
 
 
  Details
11/2/2022 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
10/19/2022 Xenon Pharmaceuticals XENE New Coverage Outperform
(N/A)
34.76
(38.89)
11.88% Details
7/29/2022 Sarepta Therapeutics SRPT Maintain Market Perform
(Market Perform)
 
 
  Details
6/24/2022 Sarepta Therapeutics SRPT Maintain Market Perform
(Market Perform)
 
 
  Details
6/21/2022 PTC Therapeutics PTCT Maintain Outperform
(N/A)
 
 
  Details
6/15/2022 Acadia Pharmaceuticals ACAD Maintain Market Perform
(N/A)
 
 
  Details
6/1/2022 Sage Therapeutics SAGE Maintain Market Perform
(Market Perform)
 
 
  Details
5/16/2022 Passage Bio Inc. PASG Maintain Outperform
(N/A)
 
 
  Details
5/4/2022 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
4/20/2022 argenx SE ARGX Maintain Strong Buy
(Strong Buy)
 
 
  Details
3/22/2022 argenx SE ARGX Maintain Strong Buy
(Strong Buy)
 
 
  Details
3/10/2022 Acadia Pharmaceuticals ACAD Maintain Market Perform
(Market Perform)
 
 
  Details
3/3/2022 Passage Bio Inc. PASG Maintain Outperform
(N/A)
 
 
  Details
3/2/2022 Sarepta Therapeutics SRPT Maintain Market Perform
(Market Perform)
 
 
  Details
2/28/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Outperform
(Outperform)
 
 
  Details
2/24/2022 Global Blood Therapeutics GBT Maintain Market Perform
(Market Perform)
 
 
  Details
2/18/2022 Agios Pharma AGIO Maintain Market Perform
(Market Perform)
 
 
  Details
2/16/2022 Sage Therapeutics SAGE Maintain Market Perform
(Market Perform)
 
 
  Details
2/11/2022 Passage Bio Inc. PASG Maintain Outperform
(Outperform)
 
 
  Details
2/11/2022 Neurocrine Bio. NBIX Maintain Outperform
(Outperform)
 
 
  Details
12/20/2021 argenx SE ARGX Maintain Strong Buy
(N/A)
 
 
  Details
12/16/2021 uniQure BV QURE Downgrade Outperform
(Strong Buy)
28.75
(26.03)
-9.46% Details
12/10/2021 Denali Therapeutics Inc. DNLI New Coverage Market Perform
(N/A)
46.16
(32.63)
-29.31% Details
12/10/2021 Biogen BIIB New Coverage Market Perform
(N/A)
234.72
(298.90)
27.34% Details
11/4/2021 Harmony Biosciences Holdings Inc. HRMY New Coverage Outperform
(N/A)
41.75
(60.48)
44.86% Details
10/29/2021 PTC Therapeutics PTCT Maintain Outperform
(N/A)
 
 
  Details
10/28/2021 argenx SE ARGX Upgrade Strong Buy
(Outperform)
279.58
(402.31)
43.9% Details
10/4/2021 Acceleron Pharma XLRN Downgrade Market Perform
(Strong Buy)
174.35
(178.75)
2.52% Details
8/20/2021 FibroGen FGEN Upgrade Market Perform
(Underperform)
12.06
(16.48)
36.65% Details
7/1/2021 Vertex VRTX New Coverage Market Perform
(N/A)
196.78
(321.37)
63.31% Details
7/1/2021 Agios Pharma AGIO New Coverage Market Perform
(N/A)
53.53
(31.52)
-41.12% Details
7/1/2021 Passage Bio Inc. PASG New Coverage Outperform
(N/A)
13.12
(1.22)
-90.7% Details
6/22/2021 Global Blood Therapeutics GBT Maintain Market Perform
(N/A)
 
 
  Details
6/1/2021 Immunovant IMVT Downgrade Market Perform
(Outperform)
15.16
(14.68)
-3.17% Details
5/6/2021 uniQure BV QURE Maintain Strong Buy
(N/A)
 
 
  Details
4/5/2021 Acadia Pharmaceuticals ACAD Downgrade Market Perform
(Outperform)
25.59
(15.76)
-38.41% Details
3/9/2021 Acadia Pharmaceuticals ACAD Downgrade Outperform
(Strong Buy)
45.78
(25.59)
-44.1% Details
2/2/2021 Immunovant IMVT Maintain Outperform
(N/A)
 
 
  Details
2/2/2021 Neurocrine Bio. NBIX New Coverage Outperform
(N/A)
109.75
(126.81)
15.54% Details
2/1/2021 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
1/19/2021 Acceleron Pharma XLRN Maintain Strong Buy
(N/A)
 
 
  Details
1/8/2021 Sarepta Therapeutics SRPT Downgrade Market Perform
(Outperform)
166.45
(126.25)
-24.15% Details
12/31/2020 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
12/16/2020 PTC Therapeutics PTCT Maintain Outperform
(N/A)
 
 
  Details
11/16/2020 Acadia Pharmaceuticals ACAD Upgrade Strong Buy
(Outperform)
50.61
(45.78)
-9.54% Details
11/6/2020 Global Blood Therapeutics GBT Downgrade Market Perform
(Outperform)
61.88
(68.49)
10.68% Details
10/26/2020 FibroGen FGEN New Coverage Underperform
(N/A)
42.60
(16.48)
-61.31% Details
8/25/2020 Immunovant IMVT Maintain Outperform
(N/A)
 
 
  Details
8/25/2020 Zogenix, Inc. ZGNX New Coverage Market Perform
(N/A)
22.94
(26.68)
16.3% Details
8/25/2020 Sarepta Therapeutics SRPT New Coverage Outperform
(N/A)
141.94
(126.25)
-11.05% Details
8/25/2020 uniQure BV QURE New Coverage Strong Buy
(N/A)
38.52
(28.75)
-25.36% Details
8/25/2020 PTC Therapeutics PTCT New Coverage Outperform
(N/A)
48.58
(42.06)
-13.42% Details
8/25/2020 Momenta Pharmaceuticals MNTA New Coverage Market Perform
(N/A)
52.32
(52.48)
0.31% Details
8/25/2020 GW Pharma GWPH New Coverage Market Perform
(N/A)
109.31
(218.96)
100.31% Details
8/25/2020 Global Blood Therapeutics GBT New Coverage Outperform
(N/A)
65.76
(68.49)
4.15% Details
8/25/2020 Immunovant IMVT New Coverage Outperform
(N/A)
32.59
(15.16)
-53.48% Details
8/25/2020 argenx SE ARGX New Coverage Outperform
(N/A)
236.18
(279.58)
18.38% Details
8/25/2020 Acadia Pharmaceuticals ACAD New Coverage Outperform
(N/A)
38.32
(15.76)
-58.87% Details